Logo image of AGYS

AGILYSYS INC (AGYS) Stock Fundamental Analysis

NASDAQ:AGYS - US00847J1051 - Common Stock

109.09 USD
-0.29 (-0.27%)
Last: 8/28/2025, 8:00:00 PM
109.09 USD
0 (0%)
After Hours: 8/28/2025, 8:00:00 PM
Fundamental Rating

5

AGYS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 282 industry peers in the Software industry. AGYS scores excellent on profitability, but there are some minor concerns on its financial health. AGYS shows excellent growth, but is valued quite expensive already. With these ratings, AGYS could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

AGYS had positive earnings in the past year.
AGYS had a positive operating cash flow in the past year.
AGYS had positive earnings in 4 of the past 5 years.
In the past 5 years AGYS always reported a positive cash flow from operatings.
AGYS Yearly Net Income VS EBIT VS OCF VS FCFAGYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M 80M

1.2 Ratios

With a decent Return On Assets value of 3.29%, AGYS is doing good in the industry, outperforming 70.21% of the companies in the same industry.
AGYS has a Return On Equity of 4.95%. This is in the better half of the industry: AGYS outperforms 70.21% of its industry peers.
AGYS has a better Return On Invested Capital (7.28%) than 78.01% of its industry peers.
AGYS had an Average Return On Invested Capital over the past 3 years of 7.16%. This is below the industry average of 11.98%.
The 3 year average ROIC (7.16%) for AGYS is below the current ROIC(7.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.29%
ROE 4.95%
ROIC 7.28%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
AGYS Yearly ROA, ROE, ROICAGYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

AGYS has a better Profit Margin (4.85%) than 68.79% of its industry peers.
AGYS's Profit Margin has improved in the last couple of years.
AGYS has a better Operating Margin (9.14%) than 73.76% of its industry peers.
AGYS's Operating Margin has improved in the last couple of years.
The Gross Margin of AGYS (62.13%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AGYS has grown nicely.
Industry RankSector Rank
OM 9.14%
PM (TTM) 4.85%
GM 62.13%
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
AGYS Yearly Profit, Operating, Gross MarginsAGYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

5

2. Health

2.1 Basic Checks

AGYS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AGYS has more shares outstanding
Compared to 5 years ago, AGYS has more shares outstanding
The debt/assets ratio for AGYS is higher compared to a year ago.
AGYS Yearly Shares OutstandingAGYS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M 25M
AGYS Yearly Total Debt VS Total AssetsAGYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 14.34 indicates that AGYS is not in any danger for bankruptcy at the moment.
AGYS's Altman-Z score of 14.34 is amongst the best of the industry. AGYS outperforms 91.13% of its industry peers.
The Debt to FCF ratio of AGYS is 0.25, which is an excellent value as it means it would take AGYS, only 0.25 years of fcf income to pay off all of its debts.
AGYS has a better Debt to FCF ratio (0.25) than 80.14% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that AGYS is not too dependend on debt financing.
AGYS has a Debt to Equity ratio (0.04) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Altman-Z 14.34
ROIC/WACC0.65
WACC11.26%
AGYS Yearly LT Debt VS Equity VS FCFAGYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 1.11 indicates that AGYS should not have too much problems paying its short term obligations.
The Current ratio of AGYS (1.11) is worse than 67.73% of its industry peers.
A Quick Ratio of 1.04 indicates that AGYS should not have too much problems paying its short term obligations.
AGYS has a worse Quick ratio (1.04) than 69.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.04
AGYS Yearly Current Assets VS Current LiabilitesAGYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

8

3. Growth

3.1 Past

AGYS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.33%, which is quite impressive.
AGYS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 47.96% yearly.
Looking at the last year, AGYS shows a quite strong growth in Revenue. The Revenue has grown by 17.92% in the last year.
AGYS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.38% yearly.
EPS 1Y (TTM)30.33%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10%
Revenue 1Y (TTM)17.92%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%20.73%

3.2 Future

The Earnings Per Share is expected to grow by 19.65% on average over the next years. This is quite good.
The Revenue is expected to grow by 21.76% on average over the next years. This is a very strong growth
EPS Next Y6.26%
EPS Next 2Y16.64%
EPS Next 3Y19.65%
EPS Next 5YN/A
Revenue Next Year13.92%
Revenue Next 2Y15.69%
Revenue Next 3Y16.84%
Revenue Next 5Y21.76%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
AGYS Yearly Revenue VS EstimatesAGYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
AGYS Yearly EPS VS EstimatesAGYS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 2

2

4. Valuation

4.1 Price/Earnings Ratio

AGYS is valuated quite expensively with a Price/Earnings ratio of 68.61.
Compared to the rest of the industry, the Price/Earnings ratio of AGYS is on the same level as its industry peers.
Compared to an average S&P500 Price/Earnings ratio of 27.17, AGYS is valued quite expensively.
Based on the Price/Forward Earnings ratio of 51.40, the valuation of AGYS can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as AGYS.
When comparing the Price/Forward Earnings ratio of AGYS to the average of the S&P500 Index (22.78), we can say AGYS is valued expensively.
Industry RankSector Rank
PE 68.61
Fwd PE 51.4
AGYS Price Earnings VS Forward Price EarningsAGYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as AGYS.
AGYS's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 64.89
EV/EBITDA 84.29
AGYS Per share dataAGYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of AGYS may justify a higher PE ratio.
AGYS's earnings are expected to grow with 19.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)10.96
PEG (5Y)1.43
EPS Next 2Y16.64%
EPS Next 3Y19.65%

0

5. Dividend

5.1 Amount

No dividends for AGYS!.
Industry RankSector Rank
Dividend Yield N/A

AGILYSYS INC

NASDAQ:AGYS (8/28/2025, 8:00:00 PM)

After market: 109.09 0 (0%)

109.09

-0.29 (-0.27%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-21 2025-07-21/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners102.65%
Inst Owner Change-1.82%
Ins Owners4.4%
Ins Owner Change0.15%
Market Cap3.06B
Analysts83.08
Price Target131.8 (20.82%)
Short Float %6.04%
Short Ratio6.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.18%
Min EPS beat(2)-10.75%
Max EPS beat(2)85.11%
EPS beat(4)3
Avg EPS beat(4)23.84%
Min EPS beat(4)-10.75%
Max EPS beat(4)85.11%
EPS beat(8)7
Avg EPS beat(8)23.11%
EPS beat(12)11
Avg EPS beat(12)23.04%
EPS beat(16)14
Avg EPS beat(16)21.73%
Revenue beat(2)2
Avg Revenue beat(2)1.53%
Min Revenue beat(2)1.11%
Max Revenue beat(2)1.95%
Revenue beat(4)2
Avg Revenue beat(4)-1.14%
Min Revenue beat(4)-6.77%
Max Revenue beat(4)1.95%
Revenue beat(8)3
Avg Revenue beat(8)-1.18%
Revenue beat(12)5
Avg Revenue beat(12)-0.58%
Revenue beat(16)7
Avg Revenue beat(16)-0.94%
PT rev (1m)4.72%
PT rev (3m)5.92%
EPS NQ rev (1m)1.32%
EPS NQ rev (3m)1.05%
EPS NY rev (1m)-0.5%
EPS NY rev (3m)-1.02%
Revenue NQ rev (1m)-0.11%
Revenue NQ rev (3m)-3.99%
Revenue NY rev (1m)0.25%
Revenue NY rev (3m)-2.54%
Valuation
Industry RankSector Rank
PE 68.61
Fwd PE 51.4
P/S 10.59
P/FCF 64.89
P/OCF 61.57
P/B 10.8
P/tB 40.72
EV/EBITDA 84.29
EPS(TTM)1.59
EY1.46%
EPS(NY)2.12
Fwd EY1.95%
FCF(TTM)1.68
FCFY1.54%
OCF(TTM)1.77
OCFY1.62%
SpS10.3
BVpS10.1
TBVpS2.68
PEG (NY)10.96
PEG (5Y)1.43
Profitability
Industry RankSector Rank
ROA 3.29%
ROE 4.95%
ROCE 8.03%
ROIC 7.28%
ROICexc 8.76%
ROICexgc 36.88%
OM 9.14%
PM (TTM) 4.85%
GM 62.13%
FCFM 16.32%
ROA(3y)11.61%
ROA(5y)4.91%
ROE(3y)17.82%
ROE(5y)7.29%
ROIC(3y)7.16%
ROIC(5y)N/A
ROICexc(3y)15.95%
ROICexc(5y)N/A
ROICexgc(3y)439.05%
ROICexgc(5y)N/A
ROCE(3y)7.91%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-16.81%
ROICexc growth 5YN/A
OM growth 3Y22.98%
OM growth 5YN/A
PM growth 3Y43.88%
PM growth 5YN/A
GM growth 3Y-0.01%
GM growth 5Y4.37%
F-Score5
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.25
Debt/EBITDA 0.33
Cap/Depr 26.88%
Cap/Sales 0.88%
Interest Coverage 250
Cash Conversion 138.51%
Profit Quality 336.48%
Current Ratio 1.11
Quick Ratio 1.04
Altman-Z 14.34
F-Score5
WACC11.26%
ROIC/WACC0.65
Cap/Depr(3y)131.65%
Cap/Depr(5y)90.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)1.97%
Profit Quality(3y)162.49%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.33%
EPS 3Y23.91%
EPS 5Y47.96%
EPS Q2Q%10%
EPS Next Y6.26%
EPS Next 2Y16.64%
EPS Next 3Y19.65%
EPS Next 5YN/A
Revenue 1Y (TTM)17.92%
Revenue growth 3Y19.23%
Revenue growth 5Y11.38%
Sales Q2Q%20.73%
Revenue Next Year13.92%
Revenue Next 2Y15.69%
Revenue Next 3Y16.84%
Revenue Next 5Y21.76%
EBIT growth 1Y17.78%
EBIT growth 3Y46.64%
EBIT growth 5YN/A
EBIT Next Year173.69%
EBIT Next 3Y69.32%
EBIT Next 5Y56.79%
FCF growth 1Y94.78%
FCF growth 3Y24.23%
FCF growth 5Y48.7%
OCF growth 1Y44.43%
OCF growth 3Y24.6%
OCF growth 5Y39.06%